AwesomeCapital
Search This Blog
Friday, February 1, 2019
Amgen Takeover of Alexion Pharma ‘Could Make Sense’ – Piper Jaffray
Piper Jaffray biotech analyst Christopher Raymond thinks an Amgen (NASDAQ: AMGN) takeover of Alexion Pharma (NASDAQ: ALXN) “could make sense.”
https://www.streetinsider.com/Analyst+Comments/Amgen+%28AMGN%29+Takeover+of+Alexion+Pharma+%28ALXN%29+Could+Make+Sense+-+Piper+Jaffray/15067398.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.